ASH-话题@MedSci

#ASH#

242篇内容 | 2152人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1301198, encodeId=13661301198f2, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=Stroke：多学科讨论：ASH/AHA科学声明——AIS静脉用阿替普酶后颅内出血怎么办？, objectType=article, longId=121587, objectId=f90512158e7b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f90512158e7b, replyNumber=0, likeNumber=67, createdTime=2017-11-29, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f90512158e7b, moduleTitle=Stroke：多学科讨论：ASH/AHA科学声明——AIS静脉用阿替普酶后颅内出血怎么办？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f90512158e7b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301197, encodeId=cd47130119e60, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=【ASH 2017】体力活动对淋巴瘤患者总生存及淋巴瘤特异性生存的重要性, objectType=article, longId=121560, objectId=98e712156019, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=98e712156019, replyNumber=0, likeNumber=55, createdTime=2017-11-29, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=98e712156019, moduleTitle=【ASH 2017】体力活动对淋巴瘤患者总生存及淋巴瘤特异性生存的重要性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=98e712156019)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301196, encodeId=88d8130119666, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=【ASH 2017】利妥昔单抗时代首次缓解后自体造血干细胞移植巩固治疗可以提高年轻套细胞淋巴瘤患者总生存, objectType=article, longId=121505, objectId=d3211215052f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3211215052f, replyNumber=0, likeNumber=64, createdTime=2017-11-28, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3211215052f, moduleTitle=【ASH 2017】利妥昔单抗时代首次缓解后自体造血干细胞移植巩固治疗可以提高年轻套细胞淋巴瘤患者总生存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3211215052f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301195, encodeId=bbdc13011954c, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=【ASH 2017】国产新药BGB-3111在惰性和侵袭性非霍奇金淋巴瘤患者中的安全性和有效性研究, objectType=article, longId=121415, objectId=c91a12141551, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c91a12141551, replyNumber=0, likeNumber=64, createdTime=2017-11-27, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c91a12141551, moduleTitle=【ASH 2017】国产新药BGB-3111在惰性和侵袭性非霍奇金淋巴瘤患者中的安全性和有效性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c91a12141551)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301194, encodeId=61d3130119452, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=J Hepatol：隐性肝硬化不同于NASH肝硬化吗？, objectType=article, longId=121374, objectId=1cc21213e45f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1cc21213e45f, replyNumber=0, likeNumber=74, createdTime=2017-11-27, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1cc21213e45f, moduleTitle=J Hepatol：隐性肝硬化不同于NASH肝硬化吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1cc21213e45f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301193, encodeId=9cca1301193a1, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=【ASH 2017】CR后一线造血干细胞移植巩固在外周T细胞淋巴瘤中的价值：一项前瞻性多中心临床研究, objectType=article, longId=120900, objectId=190612090080, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=190612090080, replyNumber=0, likeNumber=108, createdTime=2017-11-22, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=190612090080, moduleTitle=【ASH 2017】CR后一线造血干细胞移植巩固在外周T细胞淋巴瘤中的价值：一项前瞻性多中心临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=190612090080)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301192, encodeId=85cb130119262, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=ASH 2017】BCL2抑制剂venetoclax与伊布替尼联用治疗初诊未治高危和复发难治CLL的二期临床研究结果, objectType=article, longId=120735, objectId=9988120e352a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9988120e352a, replyNumber=0, likeNumber=52, createdTime=2017-11-21, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9988120e352a, moduleTitle=ASH 2017】BCL2抑制剂venetoclax与伊布替尼联用治疗初诊未治高危和复发难治CLL的二期临床研究结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9988120e352a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301191, encodeId=da2f1301191aa, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=【ASH 2017】一线免疫化疗后序贯利妥昔单抗维持治疗套细胞淋巴瘤的长期随访结果, objectType=article, longId=120688, objectId=a371120688d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a371120688d3, replyNumber=0, likeNumber=70, createdTime=2017-11-21, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a371120688d3, moduleTitle=【ASH 2017】一线免疫化疗后序贯利妥昔单抗维持治疗套细胞淋巴瘤的长期随访结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a371120688d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301190, encodeId=d3e51301190df, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=Hypertension：限钠和DASH饮食中血压变化的时间过程, objectType=article, longId=118688, objectId=1012118688d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1012118688d9, replyNumber=0, likeNumber=59, createdTime=2017-11-05, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1012118688d9, moduleTitle=Hypertension：限钠和DASH饮食中血压变化的时间过程, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1012118688d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301189, encodeId=bdeb130118908, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=AASLD2017 | HVPG可以预测NASH代偿期肝硬化患者的临床疾病进展, objectType=article, longId=117397, objectId=012411e39769, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=012411e39769, replyNumber=0, likeNumber=50, createdTime=2017-10-26, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=012411e39769, moduleTitle=AASLD2017 | HVPG可以预测NASH代偿期肝硬化患者的临床疾病进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=012411e39769)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301188, encodeId=5c2c1301188ba, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=贺林院士在ASHG 2017年会中发声，代表中国遗传咨询职业化获得国际赞誉, objectType=article, longId=117386, objectId=28c811e38668, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28c811e38668, replyNumber=0, likeNumber=73, createdTime=2017-10-26, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28c811e38668, moduleTitle=贺林院士在ASHG 2017年会中发声，代表中国遗传咨询职业化获得国际赞誉, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28c811e38668)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301187, encodeId=58cd130118ecb, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=AASLD 2017 | 范建高教授点评：HepQuant-STAT简易肝功能定量检测对NASH的无创诊断与评估, objectType=article, longId=117240, objectId=1f8211e24013, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f8211e24013, replyNumber=0, likeNumber=63, createdTime=2017-10-25, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f8211e24013, moduleTitle=AASLD 2017 | 范建高教授点评：HepQuant-STAT简易肝功能定量检测对NASH的无创诊断与评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f8211e24013)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301186, encodeId=ccb513011867d, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=Sci Rep：NASH炎症机制得到进一步阐明, objectType=article, longId=116077, objectId=1b9e1160e752, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1b9e1160e752, replyNumber=0, likeNumber=82, createdTime=2017-10-15, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1b9e1160e752, moduleTitle=Sci Rep：NASH炎症机制得到进一步阐明, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1b9e1160e752)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301185, encodeId=949013011856b, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=AHA & ASH2017联合科学年会：血压增高对机体的影响可能存在性别差异, objectType=article, longId=113929, objectId=4011113929af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4011113929af, replyNumber=0, likeNumber=64, createdTime=2017-09-25, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4011113929af, moduleTitle=AHA & ASH2017联合科学年会：血压增高对机体的影响可能存在性别差异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4011113929af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301184, encodeId=435a130118415, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=Int J Oral Max Surg：口腔肿块指示chédiak–higashi综合征, objectType=article, longId=113806, objectId=67ba113806d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=67ba113806d3, replyNumber=0, likeNumber=64, createdTime=2017-09-24, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=67ba113806d3, moduleTitle=Int J Oral Max Surg：口腔肿块指示chédiak–higashi综合征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=67ba113806d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301183, encodeId=ea4d130118313, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=Hepatology：凋亡信号调节激酶1抑制剂—Selonsertib改善NASH患者肝纤维化, objectType=article, longId=112761, objectId=ad59112e61a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad59112e61a8, replyNumber=0, likeNumber=60, createdTime=2017-09-15, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad59112e61a8, moduleTitle=Hepatology：凋亡信号调节激酶1抑制剂—Selonsertib改善NASH患者肝纤维化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad59112e61a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301182, encodeId=bf0c130118296, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=JAMA DERMAT：NASH FbiroSure可以用于监测长期接受甲氨蝶呤治疗的银屑病患者肝硬化恶化的风险, objectType=article, longId=111010, objectId=0366111010b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0366111010b5, replyNumber=0, likeNumber=68, createdTime=2017-08-28, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0366111010b5, moduleTitle=JAMA DERMAT：NASH FbiroSure可以用于监测长期接受甲氨蝶呤治疗的银屑病患者肝硬化恶化的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0366111010b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301181, encodeId=804813011819a, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=Sci Rep：外泌体在单纯性脂肪肝进展到NASH中发挥重要作用, objectType=article, longId=107865, objectId=340f10e86586, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=340f10e86586, replyNumber=0, likeNumber=83, createdTime=2017-08-07, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=340f10e86586, moduleTitle=Sci Rep：外泌体在单纯性脂肪肝进展到NASH中发挥重要作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=340f10e86586)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301180, encodeId=1794130118068, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=BMJ：高尿酸、高血压、高血糖？DASH饮食来帮忙！, objectType=article, longId=102631, objectId=d55b10263101, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d55b10263101, replyNumber=0, likeNumber=0, createdTime=2017-06-22, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d55b10263101, moduleTitle=BMJ：高尿酸、高血压、高血糖？DASH饮食来帮忙！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d55b10263101)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301179, encodeId=3be913011e92c, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=JCEM：糖尿病前期或T2DM患者以及NASH患者服用的他汀类药物的肝脏安全性如何？, objectType=article, longId=100800, objectId=6f271008006a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f271008006a, replyNumber=0, likeNumber=80, createdTime=2017-06-07, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f271008006a, moduleTitle=JCEM：糖尿病前期或T2DM患者以及NASH患者服用的他汀类药物的肝脏安全性如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f271008006a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ASH

2020-05-29

kksonne (审核中...)

前往app查看评论内容

#ASH#

Stroke：多学科讨论：ASH/AHA科学声明——AIS静脉用阿替普酶后颅内出血怎么办？

2017-11-29

kksonne (审核中...)

前往app查看评论内容

#ASH#

【ASH 2017】体力活动对淋巴瘤患者总生存及淋巴瘤特异性生存的重要性

2017-11-29

kksonne (审核中...)

前往app查看评论内容

#ASH#

【ASH 2017】利妥昔单抗时代首次缓解后自体造血干细胞移植巩固治疗可以提高年轻套细胞淋巴瘤患者总生存

2017-11-28

kksonne (审核中...)

前往app查看评论内容

#ASH#

【ASH 2017】国产新药BGB-3111在惰性和侵袭性非霍奇金淋巴瘤患者中的安全性和有效性研究

2017-11-27

kksonne (审核中...)

前往app查看评论内容

#ASH#

J Hepatol：隐性肝硬化不同于NASH肝硬化吗？

2017-11-27

kksonne (审核中...)

前往app查看评论内容

#ASH#

【ASH 2017】CR后一线造血干细胞移植巩固在外周T细胞淋巴瘤中的价值：一项前瞻性多中心临床研究

2017-11-22

kksonne (审核中...)

前往app查看评论内容

#ASH#

ASH 2017】BCL2抑制剂venetoclax与伊布替尼联用治疗初诊未治高危和复发难治CLL的二期临床研究结果

2017-11-21

kksonne (审核中...)

前往app查看评论内容

#ASH#

【ASH 2017】一线免疫化疗后序贯利妥昔单抗维持治疗套细胞淋巴瘤的长期随访结果

2017-11-21

kksonne (审核中...)

前往app查看评论内容

#ASH#

Hypertension：限钠和DASH饮食中血压变化的时间过程

2017-11-05

kksonne (审核中...)

前往app查看评论内容

#ASH#

AASLD2017 | HVPG可以预测NASH代偿期肝硬化患者的临床疾病进展

2017-10-26

kksonne (审核中...)

前往app查看评论内容

#ASH#

贺林院士在ASHG 2017年会中发声，代表中国遗传咨询职业化获得国际赞誉

2017-10-26

kksonne (审核中...)

前往app查看评论内容

#ASH#

AASLD 2017 | 范建高教授点评：HepQuant-STAT简易肝功能定量检测对NASH的无创诊断与评估

2017-10-25

kksonne (审核中...)

前往app查看评论内容

#ASH#

Sci Rep：NASH炎症机制得到进一步阐明

2017-10-15

kksonne (审核中...)

前往app查看评论内容

#ASH#

AHA & ASH2017联合科学年会：血压增高对机体的影响可能存在性别差异

2017-09-25

kksonne (审核中...)

前往app查看评论内容

#ASH#

Int J Oral Max Surg：口腔肿块指示chédiak–higashi综合征

2017-09-24

kksonne (审核中...)

前往app查看评论内容

#ASH#

Hepatology：凋亡信号调节激酶1抑制剂—Selonsertib改善NASH患者肝纤维化

2017-09-15

kksonne (审核中...)

前往app查看评论内容

#ASH#

JAMA DERMAT：NASH FbiroSure可以用于监测长期接受甲氨蝶呤治疗的银屑病患者肝硬化恶化的风险

2017-08-28

kksonne (审核中...)

前往app查看评论内容

#ASH#

Sci Rep：外泌体在单纯性脂肪肝进展到NASH中发挥重要作用

2017-08-07

kksonne (审核中...)

前往app查看评论内容

#ASH#

BMJ：高尿酸、高血压、高血糖？DASH饮食来帮忙！

2017-06-22

kksonne (审核中...)

前往app查看评论内容

#ASH#

JCEM：糖尿病前期或T2DM患者以及NASH患者服用的他汀类药物的肝脏安全性如何？

2017-06-07

科室
- - 订阅+
  - 更多科室
工具
服务